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ABSTRACT Myosin cross-bridges play an important role in the regulation of thin-ﬁlament activation in cardiac muscle. To test
the hypothesis that sarcomere length (SL) modulation of thin-ﬁlament activation by strong-binding cross-bridges underlies the
Frank-Starling mechanism, we inhibited force and strong cross-bridge binding to intermediate levels with sodium vanadate
(Vi). Force and stiffness varied proportionately with [Ca2þ] and [Vi]. Increasing [Vi] (decreased force) reduced the pCa50 of
force-[Ca2þ] relations at 2.3 and 2.0 mm SL, with little effect on slope (nH). When maximum force was inhibited to ~40%, the
effects of SL on force were diminished at lower [Ca2þ], whereas at higher [Ca2þ] (pCa < 5.6) the relative inﬂuence of SL on force
increased. In contrast, force inhibition to ~20% signiﬁcantly reduced the sensitivity of force-[Ca2þ] relations to changes in both SL
and myoﬁlament lattice spacing. Strong cross-bridge binding cooperatively induced changes in cardiac troponin C structure, as
measured by dichroism of 50 iodoacetamido-tetramethylrhodamine-labeled cardiac troponin C. This apparent cooperativity was
reduced at shorter SL. These data emphasize that SL and/or myoﬁlament lattice spacing modulation of the cross-bridge compo-
nent of cardiac thin-ﬁlament activation contributes to the Frank-Starling mechanism.INTRODUCTION
The Frank-Starling relation describes the intrinsic ability of
the heart to increase ventricular systolic force and stroke
volume in response to increased ventricular filling in dias-
tole. The cellular basis for this is the steep sarcomere length
(SL) dependence of twitch contraction in myocytes, and
underlying this is the enhanced sensitivity of the contractile
apparatus to myoplasmic [Ca2þ] when SL is increased (for
review see Gordon et al. (1)). The mechanisms underlying
SL-dependent activation of force have remained elusive,
but they likely involve a complex interplay of the influences
of Ca2þ and acto-myosin cross-bridge binding on thin-fila-
ment activation (for review see Fuchs and Martyn (2)). It
is the purpose of this study to investigate the role that modu-
lation of strong cross-bridge binding plays in SL dependence
of contractile activation in cardiac muscle. It is important to
understand the cellular and molecular mechanisms of the
Frank-Starling relation because changes in the SL depen-
dence of cardiac force may be an important component of
heart failure (3).
After Ca2þ is released from intracellular stores, Ca2þ
binding to the regulatory protein complex troponin (Tn) on
thin filaments is the initial step in contractile activation.
This allows movement of tropomyosin (Tm) on the surface
of thin filaments, exposing binding sites for cross-bridges
on actin. The formation of strong actin/cross-bridge interac-
tions further activates thin filaments by contributing to the
displacement of Tm into the ‘‘on’’ position. Thus, thin-fila-
ment activation (defined as the availability of binding sites
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force) is dependent on feedback cooperative activation by
cross-bridges (1,2,4). A unique additional feature of cardiac
contractile activation is the ability of strong cross-bridge
interaction with thin filaments to increase the Ca2þ affinity
of cardiac troponin C (cTnC) (5–8). This constitutes an
additional and potentially important feedback pathway for
thin-filament activation by strong-binding cross-bridges. We
recently proposed that length controls the sensitivity of force
to myoplasmic [Ca2þ] in cardiac muscle by direct modulation
of cross-bridge proximity and binding to thin filaments (9,10).
In this scheme, increasing myofilament lattice spacing
(MFLS) at short SL decreases cross-bridge proximity to thin
filaments. This reduces both the probability of strong cross-
bridge binding to thin filaments and cross-bridge-induced
thin-filament activation at a given myoplasmic [Ca2þ] (10).
If this idea is true, then the sensitivity of cardiac force-
[Ca2þ] relations to SL or MFLS should depend on the size
of the cross-bridge population available for strong binding,
and perhaps require a minimal level of cross-bridge binding
and force. To test this idea, we measured the effects of SL
and MFLS on force-[Ca2þ] relations in skinned right ventric-
ular trabeculae from rat hearts when strong cross-bridge
binding and force were inhibited to intermediate levels with
sodium vanadate (Vi). Vi was utilized in previous studies to
reveal strong cross-bridge enhancement of Ca2þ binding to
cTnC and Ca2þ-induced structural changes in cTnC (5–8).
We recently showed that Vi inhibits force primarily by shifting
the population of cycling cross-bridges toward stable weak-
binding states with very slow attachment/detachment kinetics,
and to detached states that contributed little to thin-filament
activation (11). Thus Vi enables the population of cycling
cross-bridges that contribute to thin-filament activation to be
doi: 10.1016/j.bpj.2009.02.018
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directly monitor the contribution of strong cross-bridge
binding to thin-filament activation, we measured the relation
between maximal Ca2þ-activated force (Fmax) and dichroism
of cTnC fluorescently labeled with 50 iodoacetamido-tetrame-
thylrhodamine (50IATR) in skinned trabeculaewhen forcewas
inhibited over a range of [Vi] values (7,8).
Increasing [Vi] reduced the Ca2þ-sensitivity of force
(pCa50) at both 2.3 and 2.0 mm SL. Force inhibition by
<60% increased the SL dependence of force at both maximal
activation and over a range of submaximal [Ca2þ]. In contrast,
force inhibition by>60% significantly reduced the SL depen-
dence of both maximal Fmax and pCa50. At levels of inhibition
that reduced SL effects on force, the sensitivity of force-
[Ca2þ] relations to altered MFLS was also diminished. Fluo-
rescence measurements from (50IATR)-labeled cTnC on
cardiac thin filaments indicate that cross-bridge-induced
changes in cTnC structure are cooperative, and that this
apparent cooperativity is reduced at short SL compared with
long SL. These results support the hypothesis that an impor-
tant component of the Frank-Starling mechanism in cardiac
muscle is the ability of changes in SL and/or MFLS to modu-
late strong cross-bridge binding to, and subsequent coopera-
tive activation of, cardiac thin filaments.
MATERIALS AND METHODS
Cardiac trabeculae preparation
Single cardiac trabeculae were prepared from male Sprague-Dawley rats
(200–250 g) as described previously (7). Briefly, rats were anesthetized by
an intraperitoneal injection of pentobarbital (50 mg/kg) and their hearts
were removed rapidly and placed in oxygenated, physiological salt solution
(in mM: 100 NaCl, 24 NaHCO3, 2.5 KCl, 1 MgS04.7H2O, 1 NaHPO4, and 1
CaCl2. Small trabeculae (100–200 mm in diameter, 1–2 mm long) were
dissected from the right ventricle and their surface membranes were
rendered permeable to bathing solution constituents by exposing them for
12 h at 4C to a skinning solution containing (in mM) 100 KCl, 9.0 MgCl2,
4.0 MgATP, 5.0 K2 ethylene glycol-bis-(b-aminoethylether)-N,N,N,N-tetra-
acetic acid (EGTA), 10 3-(N-morpholino) propane sulfonic acid (MOPS),
1% (v/v) nonionic detergent Triton X-100, pH 7.0, and 50% (v/v) glycerol
and 1% (v/v) protease inhibitor cocktail (P-8340; Sigma, St. Louis, MO).
The skinned trabeculae were stored in the same solution without Triton
X-100 at 20C and used for experiments within 1 week. On average, the
trabeculae dimensions were 1.43  0.06 mm  176  13 mm (length 
diameter; mean  standard error (SE); n ¼ 10).
Mechanics measurements
The ends of single trabeculae were wrapped in aluminum foil T-clips for
attachment to a force transducer (model 400A, 2.2 kHz resonant frequency;
Cambridge Technology, Watertown, MA) and a servomotor (model 300;
Cambridge Technology) tuned for a 350 ms step response. SL was measured
and adjusted under relaxing conditions using laser diffraction techniques as
described previously (12). Force, length, and SL signals were low-pass
filtered (fc ¼ 40% of the sampling rate) with a CyberAmp 380 (Axon Instru-
ments, Foster City, CA) and recorded digitally with a 12-bit resolution. All
experiments were done at 15C. Stiffness was measured by applying a 500
Hz sinusoidal length change (0.015 mL lengths) to the fiber. Stiffness was
determined from the ratio of the peaks of the Fourier transforms of the force
and ML signals.Fluorescence measurements
Endogenous cTnC was extracted from skinned trabeculae and replaced with
a mono-cysteine cTnC mutant cTnC(C35S) that had been labeled at Cys84
with 50-iodoacetamide tetramethylrhodamine (50IATR) as described previ-
ously (7,8). To monitor Ca2þ and cross-bridge-induced changes in cTnC
structure, the dichroism of the 50IATR probe was measured. Because the
dichroism signal is expressed as a ratio to total fluorescence, it is much
less sensitive to changes in fluorescence intensity that occur when SL is
altered and the amount of fluorophore in the optical field changes. During
the dichroism measurements the fiber was illuminated by an Hg vapor
lamp (HBO 50/3, OSRAM GmbH, FRG) filtered at 540  5 nm, and then
passed through a 12% neutral density and polarizing filter oriented perpen-
dicular to the fiber axis for excitation of 50IATR-labeled cTnC. The polari-
zation angle of the exciting light was sinusoidally (42 kHz) alternated
parallel and perpendicular to the fiber axis by a photoelastic modulator
(PEM, model 80; Hinds, Portland, OR) with the peak-to-peak retardation
set to 413 nm. The light emitted after absorption by the probe (590–630 nm)
was collected by the objective (NA ¼ 0.32) and focused onto a photomulti-
plier tube (type R938HA; Hamamatsu, Hamamatsu City, Japan). The output
of the photomultiplierwasmonitoredwith awide band-pass current to voltage
converter (3 db @ 450 kHz). To determine the root mean-square (RMS)
amplitude of the sinusoidally varying difference in fluorescence intensity
parallel (It) and perpendicular (Ill) to the fiber axis, the output of the amplifier
was directed to a lock-in amplifier (model 3961B; Ithaco, Ithaca, NY).Details
of the apparatus and protocols are described elsewhere (7,8).
Dichroism or polarization anisotropy (r) was measured and expressed
using the equation given by Tanner et al. (13) as:
r ¼ ð  2D=LÞ=6J2ðfÞ þ ð1 3JoðfÞD=LÞ;
where D is the RMS value of Ill  It (from the output of the lock-in ampli-
fier), and L is the total fluorescence (Ill þ 2It). The retardation of PEM was
set so that the zeroth-order Bessel function (Jo) was zero. Further details of
the optical measurements are described in Martyn et al. (14).
The magnitude of dichroism depends on the average orientation of the
population of probes with respect to the ‘‘magic angle’’, at which dichroism
would be zero. Thus, an increase in dichroism could indicate either an
increase in the degree of order of the population of probes or a change in
average orientation of the probes, so that they become more oriented parallel
to the fiber axis. Likewise, decreasing dichroism would indicate that either
the average angle of the probes approached the ‘‘magic angle’’ or the probes
became more disordered. Measurements of linear dichroism do not allow
distinction between these possible mechanisms, although recent EPR
measurements of maleimide-labeled TnC indicated that Ca2þ binding to
TnC causes both disorder and angle changes (15), and fluorescence polari-
zation measurements of 50IATR cTnC(C35S) in guinea pig skinned cardiac
trabeculae indicated that changes in dichroism occur primarily as a result of
changes in probe angle (16).
Solutions
The solutions contained (in mM) 15 phosphocreatine, 15 EGTA, 80 MOPS,
1 Mg2þ, 135 Naþ þKþ, 1 dithiothreitol (DTT), 250 U mL1 creatine kinase
(CK; Sigma), and 5 mM ATP at pH 7.0 and ionic strength 0.17 M. For acti-
vation solutions, [Ca2þ] (expressed as pCa ¼ log [Ca2þ]) was varied by
adding Ca2þ propionate. In a subset of experiments, Dextran T500 (4% w/v)
was added to all solutions. Vi was prepared as described by Goodno (17) and
added to the bathing solutions from a 100 mM stock solution.
Data analysis
Force-pCa data were fit by the Hill equation, where Fmax is the maximally
activated force, nH is
F ¼ Fmax=

1 þ 10nHðpCa50pCaÞBiophysical Journal 96(9) 3692–3702
3694 Smith et al.the Hill coefficient or slope, and pCa50 is the pCa at which force is half-
maximal. The reported pCa50 and nH values represent the means of the values
from the individual fits  SE. The means were compared with the use of
Student’s t-test, with significance at the 95% confidence level (p < 0.05).
RESULTS
Effects of Vi on force and force-[Ca2þ] relations
To study the role of strong cross-bridge binding in the SL
dependence of cardiac force, it was necessary to determine
the [Vi] necessary to achieve selected levels of force inhibi-
tion.MaximumCa2þ-activated force (pCa 4.5) wasmeasured
at 2.0 () and 2.3 (B) mm SL in the presence of varying Vi
concentrations (0–0.3 mM) in single skinned cardiac trabec-
ulae. The summarized data (mean  SE) from seven trabec-
ulae are shown in Fig. 1. Force was expressed relative to
maximal Ca2þ-activated force (pCa 4.5) at 2.3mmSL in unin-
hibited controls. The apparent sensitivity of maximum force
to Vi was greater at short SL, being inhibited to 50% of its
maximum value at ~0.06 mM Vi vs. ~0.08 mM at longer SL.
Based on the data in Fig. 1, the force-[Ca2þ] relations
shown in Fig. 2 were measured with 0.05, 0.10, and 0.30 mM
Vi in all bathing solutions to inhibit Fmax at 2.3 mm SL
to 66% (;), 40% (-), and 20% (A) of controls (; no Vi),
respectively. The effects of Vi on force-[Ca2þ] relations were
measured at 2.3 (solid symbols) and 2.0 mm SL (open
symbols). Data (mean  SE) were obtained from nine (),
six (:), seven (-), and six (A) trabeculae, and were fit
with the Hill equation. The pCa50 and nH values for each
condition are summarized in Table 1.
Inspection of Fig. 2 suggests that increasing [Vi] and
greater force inhibition had a complex effect on the SL
dependence of Fmax, in addition to effects on pCa50. This
FIGURE 1 Effects of increasing [Vi] on maximum Ca2þ-activated force
(pCa 4.5) were obtained at 2.3 () and 2.0 (B)mm SL. Data (mean  SE)
were obtained from seven trabeculae. The approximate [Vi] at which
maximal force was inhibited to 50% of controls (no Vi) are indicated for
data obtained at 2.0 (small dotted line) and 2.3 mm SL (thin solid line),
respectively.Biophysical Journal 96(9) 3692–3702is emphasized by Fig. 3, which illustrates the effect of force
inhibition on the relationship of both maximal force (pCa
4.5) at long versus short SL (Fig. 3 A) and the effect of Vi
on pCa50 at long and short SL (Fig. 3 B). When maximal
force at 2.3 mm SL was inhibited by Vi to either ~60%
(0.05 mM Vi) or ~40% (0.10 mM Vi) of control, the relative
degree of inhibition was greater at 2.0 mm SL (Fig. 1). As
a result, the ratio of maximum force at long versus short
SL at 2.3–2.0 mm SL increased (Fig. 3 A), whereas absolute
force decreased at both lengths (Fig. 2). In comparison, inhi-
bition of maximal force by ~80% (0.30 mM Vi) significantly
reduced the SL dependence of Fmax. In contrast to maximal
force, Fig. 3 B illustrates that increasing force inhibition
decreased pCa50 of force-[Ca
2þ] relations at both 2.3 ()
and 2.0 (B) mm SL. In Fig. 3 B the arrows connect the
pCa50 values obtained at long and short SL at the [Vi] indi-
cated next to the arrows (mM). Whereas force inhibition
decreased pCa50, the effect was maximal for both SLs at
0.05 mM Vi, with lesser decreases at higher [Vi] (Table 1).
The pCa50 and nH values obtained at both SLs, along with
the differences in pCa50 (DpCa50) obtained at each [Vi],
are included in Table 1.
Although the data in Figs. 2 and 3 describe the effects of
force inhibition by Vi on the SL dependence of maximal
force and pCa50, a more complete description of the enhance-
ment of force by increasing SL at all activating [Ca2þ] and
[Vi] can be obtained by subtracting the Hill fits at short SL
in Fig. 2 from the corresponding curves at long SL, as we
previously described (9). The resulting relationship, illus-
trated in Fig. 4, represents force enhancement by increasing
SL over the entire force-[Ca2þ] relationship. In Fig. 4 A,
force enhancement is expressed as a fraction of Fmax at
FIGURE 2 Force-[Ca2þ] relations were measured at 2.0 mm (open
symbols) and 2.3 mm (solid symbols) SL in the presence of zero Vi (,
B), 0.05 (;, 6), 0.10 (-,,) and 0.3 mM Vi (A,>). Data (mean 
SE) for each condition were obtained from 10, 6, 7, and 6 trabeculae, respec-
tively. The levels of force inhibition for each [Vi] and both SLs, along with
the Hill fit parameters for the force-[Ca2þ] relations (pCa50 and nH), are
included in Table 1.
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[NaVi] (mM) SL (mm) Dex (%) N Fmax* SEM Fmax
y ratio SEM nH SEM pCa50 SEM DpCa50
z SEM
0.00 2.3 10 1.00 0.00 1.24 0.03 5.5 0.6 5.71 0.02 0.09 0.01
2.0 10 0.81 0.02 5.5 0.6 5.62 0.03
0.05 2.3 6 0.66 0.02 1.46 0.04 6.1 0.5 5.58 0.01 0.06 0.01
2.0 6 0.45 0.02 7.2 1.1 5.52 0.01
0.10 2.3 7 0.40 0.03 1.52 0.11 5.9 0.9 5.57 0.03 0.06 0.02
2.0 7 0.27 0.02 5.0 0.2 5.52 0.03
0.30 2.3 6 0.20 0.02 1.14 0.07 5.4 1.2 5.52 0.03 0.04 0.01
2.0 6 0.18 0.03 4.9 0.9 5.48 0.03
0x 2.0 4% 8 1.17 0.08 1.17 0.08 3.5 0.6 5.58 0.06 0.13 0.06
2.0 8 1.00 0.00 5.1 0.6 5.45 0.06
0.30 2.0 4% 8 0.29 0.03 1.39 0.12 8.6 1.6 5.29 0.06 0.08 0.04
2.0 8 0.22 0.03 6.7 1.1 5.20 0.06
*Fmax is taken as a fraction of force at pC 4.5 and 2.3 tm SL within the same fiber.
yThe Fmax ratio is the ratio of maximal force (pCa 4.5) obtained at 2.3 vs. 2.0 mm SL.
zDpCa50 is calculated from the Hill fits to data from individual trabeculae.
xData in Vi experiments and those with Dextran were obtained with different batches of animals.2.3 mm SL in uninhibited controls, and in Fig. 4 B it is
expressed relative to the maximal force obtained at 2.3 mm
SL for each level of force inhibition (see figure legend). As
we found in a previous study (9), the relative force increase
from increasing SL was greatest at submaximal force levels
(pCa 5.6–5.4), near the pCa50 at short SL for controls
(Table 1). Inhibition of maximal force by ~40% with
0.05 mM Vi induced a shift of the curves to higher [Ca2þ]
(consistent with decreasing pCa50 in Fig. 3) and reduced
the peak of SL dependence at submaximal [Ca2þ] compared
with controls. At [Ca2þ] above pCa 5.2, the relative effect of
increasing SL on force was the same as for controls, although
the absolute level of maximal force was reduced at both SLs.
In addition to decreasing the apparent Ca2þ sensitivity of
force (Fig. 3, Table 1), the primary effect of greater force
inhibition by increasing [Vi] to 0.10 and 0.30 mM was to
progressively reduce the effect of SL on force at all acti-
vating [Ca2þ] (Fig. 4 A). When force was expressed as a
fraction of the maximum Ca2þ-activated force obtained at
2.3 mm SL for each condition (Fig. 4 B), the data indicate
that increasing [Vi] from 0 to 0.30 mM not only reduced
Fmax and decreased pCa50, it also reduced the effect of
increasing SL on submaximal force from pCa 6.0 to ~5.6,
a range that includes the pCa50 for force-[Ca
2þ] relations
at both SLs (Table 1). This is significant because cardiac
myocytes are activated at submaximal levels under normalphysiological conditions (18,19). In contrast, for [Ca2þ] >
pCa 5.6, relative force enhancement by increasing SL was
greater with 0.05 and 0.10 mM Vi (dotted and dashed curves
in Fig. 4 B). This contrasts with data obtained when force
was inhibited to ~20% of Fmax with 0.30 mM Vi (Fig. 4 B,
dotted-dashed curve). In this case, force enhancement by
increasing SL was significantly reduced over the full range
of activating [Ca2þ].
We recently showed that inhibition ofmaximumCa2þ-acti-
vated force with Vi was associated with decreased strong
cross-bridge binding to cardiac thin filaments (11). To demon-
strate that this holds true at both maximal and submaximal
levels of Ca2þ activation in the absence and presence of Vi,
stiffness was measured by small-amplitude (0.5% ML),
500HZ sinusoidal oscillation ofML. Fig. 5 compares the rela-
tionship between stiffness and force at different [Ca2þ] levels
when SL was 2.0 mm (open symbols) and 2.3 mm (solid
symbols). Stiffness and force at both SLs was expressed as
a fraction of the value at pCa 4.5 at 2.3 mm SL in controls.
Fmax at 2.3 mm SL was inhibited to ~60% (Fig. 4 B) or
~20% (Fig. 4C) Fmax by Vi. Data (mean SE) were obtained
from seven trabeculae. At a given level of force inhibition,
stiffness and force declined in nearly direct proportion to
decreasing [Ca2þ]. Although increasing [Vi] inhibited force
slightly more than stiffness (11), there was no significant
difference between the stiffness-force relations at either SL.BA FIGURE 3 (A) To demonstrate changes in the SL depen-
dence of maximal force (pCa 4.5) at varying degrees of
force inhibition with Vi, the SL dependence of maximal
force is expressed as the ratio of force obtained at 2.3 vs.
2.0 mm SL. Data were obtained from the same trabeculae
as in Fig. 2. Panel B illustrates the dependence of pCa50
at 2.0 mm (B) and 2.3 mm () SL on the level of force inhi-
bition by Vi; data were obtained from the same experiments
as in Fig. 2. Data obtained with a long and short SL for
a given [Vi] are connected by arrows, with the [Vi] indi-
cated in mM next to each pair.Biophysical Journal 96(9) 3692–3702
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FIGURE 4 To demonstrate the enhancement of force
when SL was increased from 2.0 to 2.3 mm over the full
range of activating [Ca2þ], the Hill fit curves to the data
in Fig. 2 at 2.0 mm SL were subtracted from the curves ob-
tained at 2.3 mm SL for 0 (solid line), 0.05 (dotted line),
0.10 (dashed line), and 0.30 (dot-dashed line) mM Vi.
(A) Force is expressed relative to maximum control (pCa
4.5) at 2.3 mm SL without Vi. (B) Force is expressed rela-
tive to the maximum force obtained at 2.3 mm SL for
each [Vi].The results indicate that at eachSL, the force and the population
of strongly bound, force-generating cross-bridges decreased in
roughly the same proportion with both increasing [Vi] and
decreasing [Ca2þ].
We, as well as other investigators, have suggested that the
altered spacing between thick and thin filaments (MFLS) that
accompanies changing SL may play an important role in the
mechanisms underlying the SL dependence of force in
cardiac muscle (for review see Fuchs and Martyn (2)).
Like increasing SL (9), decreasing MFLS at short SL by
osmotic compression of trabeculae with Dextran T500
increases both Fmax and pCa50 (9,20). To test whether strong
inhibition of cross-bridge binding to cardiac thin filaments
can reduce the MFLS dependence of force-[Ca2þ] relations,
as found for the effect of SL on force (Fig. 3, Table 1), we
compared the effects of adding 4% Dextran T500 on force-
[Ca2þ] relations at 2.0 mm SL in the absence of Vi and
when maximum force was inhibited by Vi to ~20% of
control (Fig. 6, Table 1). We found that 4% Dextran T500
caused about the same decrease in MFLS in skinned trabec-
ulae (10) as observed when SL increased from 2.0 to 2.3 mm
in intact cardiac trabeculae (21). The data (mean SE; n¼ 8
trabeculae) shown in Fig. 6 were obtained at 2.0 mm SL
without Dextran (open symbols) and with 4% Dextran
(closed symbols) in both controls (circles; no Vi) and when
Fmax was inhibited by ~80% by Vi (triangles). In Fig. 6 A
force is expressed as a fraction of Fmax at 2.0 mm SL in
controls, with no Vi. In Fig. 6 B the same data as in Fig. 6 A
are shown with force is expressed as a fraction of maximumBiophysical Journal 96(9) 3692–3702force obtained at pCa 4.5 at each SL and for each condition.
The data were fit with the Hill equation, and the values of
pCa50 and nH are included in Table 1 along with a compar-
ison of the effects of Dextran on Fmax at each SL. The data in
Fig. 6 and Table 1 indicate that increased pCa50 from
osmotic lattice compression in controls was significantly
diminished when force was inhibited to ~20% of maximum.
This supports the idea that, like SL, MFLS effects on force-
[Ca2þ] relations result from modulation of the population of
strong-binding cross-bridges.
One interpretation of the diminished SL and MFLS depen-
dence of force at higher [Vi] in Figs. 2–4 and 6 is that the
reduction of the population of strong-binding cross-bridges
and force by >60% significantly reduces or even eliminates
the ability of cross-bridges to cooperatively activate cardiac
thin filaments (2,11). Under these conditions, changes in SL
or MFLS would be expected to have a minimal impact on the
level of thin-filament activation and force. To test this idea
more directly, we monitored Ca2þ and cross-bridge-induced
changes in cTnC structure on thin filaments using fluores-
cence techniques, as we did previously (7,8). This approach
is justified by the findings that strongly bound cross-bridges
increase Ca2þ binding to thin filaments in cardiac muscle
(22). A mono-cysteine mutant cTnC (cTnC(C35S) was
labeled at Cys84 with 50 iodoacetamido-tetramethyl rhoda-
mine (50IATR). Endogenous cTnC was extracted from
skinned trabeculae and replaced with the cTnC(C35S)
50IATR-labeled mutant. Changes in dichroism of the 50IATR
probe were measured to monitor alterations of cTnC structureCBA FIGURE 5 The relationship between
sinusoidal stiffness and force at
different [Ca2þ] levels when SL was
2.3 mm (solid symbols) or 2.0 mm
(open symbols) is illustrated for controls
(A) and when force was inhibited by
0.05 (B) and 0.30 (C) mM Vi. In B
and C the solid and dashed lines repre-
sent the stiffness-force relations in A at
2.0 and 2.3 mm SL, respectively. The
force and stiffness data are scaled differ-
ently in each panel. A solid unity line is
included in each panel for comparison.
Data (mean  SE) were obtained from
6 to 10 trabeculae.
Length-Dependent Activation in Muscle 3697BA FIGURE 6 Effect of osmotic compression with 4%
Dextran T500 on force-[Ca2þ] relations measured at
2.0 mm SL. In panel A, force is expressed as a fraction of
Fmax at 2.3 mm SL in controls. The same data are shown
in B with force expressed as a fraction of the maximum
force obtained for each condition. Measurements were
made in the absence (solid symbols) and presence (open
symbols) of 4% Dextran T500 in controls (circles) and
when force was inhibited by 0.3 mM Vi (triangles). The
data were fit with the Hill equation; pCa50 and nH values
are included in Table 1. Data were obtained from five
trabeculae.on cardiac thin filaments. We previously showed that
maximal force inhibition decreased dichroism at maximal
[Ca2þ] (pCa 4.5) by ~20% (7,8). In the study presented
here, we measured dichroism at pCa 4.5 at both 2.3 and
2.0 mm SL, when maximal force was inhibited at varying
[Vi]. To avoid biasing, the order of SL at which data were
acquired was reversed. Data (mean  SE; n ¼ 4) are shown
in Fig. 7. In Fig. 7 A force and dichroism are compared for
relaxed and maximally Ca2þ-activated controls, and when
force was maximally inhibited with 1.0 mM Vi. In controls,
maximum Ca2þ-activation increased dichroism 2.77 
0.03-fold compared with pCa 9.2, in accordance with our
previous results (7,8). In the presence of 1.0 mM Vi, force
was 5  1.0% of control, and dichroism was 2.55  0.03-
fold greater than in relaxing solution, corresponding to
a ~13% decrease from pCa 4.5 without Vi. Stiffness and force
were inhibited to the same extent by 1.0 mM Vi.
Fig. 7 B illustrates the effect of increasing [Vi] and
increasing force inhibition at maximal [Ca2þ] (pCa 4.5) on
50IATR-labeled cTnC(C35S) dichroism in skinned cardiac
trabeculae at 2.0 (B) and 2.3 () mm SL. Changes in
dichroism are expressed as a fraction of the difference
between controls at pCa 4.5 (with no Vi) and when force
was maximally inhibited with 1.0 mM Vi, and are plotted
against the level of force (pCa 4.5) obtained at various [Vi]
levels. The level of dichroism at pCa 9.2 (relaxing) was the
same before and after inhibition of maximal force (pCa 4.5)
with 1.0 mM Vi, indicating that cross-bridges ‘‘trapped’’ in
the Vi-bound state (11) did not alter cTnC structure in the
absence of Ca2þ. The effect of increasing [Vi] on dichroism
at pCa 4.5 differed between long and short SLs. At 2.3 mm
SL increasing [Vi] decreased force at pCa 4.5 to a greaterextent than dichroism, whereas at 2.0 mm SL maximal force
and dichroism declined more proportionately. Increasing
[Vi] inhibited force and stiffness to the same extent at both
SLs (Fig. 5), indicating that changes in force were associated
with a proportionate decrease in strong cross-bridge/thin-
filament interactions. The greater effect of Vi on force than
on activation-induced changes in cTnC structure at long
SL implies that the effect of cycling cross-bridges on thin-
filament activation may be cooperative. If this were not the
case, the decline of dichroism with force (and stiffness) with
increasing [Vi] would be more proportionate. By contrast,
at short SL and increasing [Vi], dichroism decreased more
linearly with force, indicating a reduction in the ability
of cross-bridges to cooperatively induce changes in cTnC
structure.
DISCUSSION
The inhibition of force and strong cross-bridge binding by Vi
has complex effects on the SL dependence of force-[Ca2þ]
relations in cardiac muscle. In a previous work (11) we
argued that force inhibition by Vi was associated with a par-
titioning of the cross-bridge population between those with
normal cycling kinetics and a subpopulation in a relatively
stable Vi-bound state; the Vi-bound state exhibited weak
binding to thin filaments, with very slow apparent attach-
ment/detachment kinetics. As a result, in the presence of
Vi, force likely results from a subpopulation of cross-bridges
with normal cycling kinetics, the size of which can be
controlled by [Vi], rather than from cross-bridges in rapid
equilibrium between a number of weak- and strong-binding
states (11). In this study, the Ca2þ sensitivity of force (pCa50)A B FIGURE 7 (A) Changes in force (open bars) and
dichroism (solid bars) of trabeculae that contain 50IATR-
labeled cTnC(C35S) are compared in relaxing, (pCa 9.2)
and maximally activating (pCa 4.5) solutions, and when
force and stiffness (pCa 4.5) were maximally inhibited
with 1.0 mM Vi. (B) The relative change in dichroism is
plotted versus maximum force (pCa 4.5), at various levels
of force inhibition with Vi (0–1.0 mM). Data (mean 
SE) were obtained from 4 trabeculae at 2.3 () and 2.0
(B) mm SL. The change in dichroism after force inhibition
at a given [Vi] is expressed as a fraction of the difference
between controls (pCa 4.5) with no Vi and dichroism at
pCa 4.5 in the presence of 1.0 mM Vi (A).Biophysical Journal 96(9) 3692–3702
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2.0 mm SL, pCa50 decreased the most at 0.05 mM Vi, where
Fmax at 2.3 um SL was reduced by ~40%, and increasing [Vi]
resulted in a smaller reduction of pCa50 at both SLs (Fig. 3 B
and Table 1). Force inhibition decreased the effect of SL on
pCa50 (DpCa50; Fig. 3 B and Table 1). To further characterize
the effects of force inhibition on length-dependent activation,
we described the Ca2þ dependence of the force enhancement
when SL was lengthened from 2.0 to 2.3 mm at various [Vi]
levels (Fig. 4). Concentrations of Vi that inhibited Fmax at
longer SL by <60% resulted in greater relative force
enhancement at pCa > ~5.6 when SL was increased
(Fig. 4 B). In contrast, >60% inhibition of force reduced
both the SL and MFLS dependence of force at all activating
[Ca2þ] (Figs. 3, 4, and 6). We also observed that the ability
of cycling, strong-binding cross-bridges to cooperatively
activate thin filaments (indicated by cross-bridge-induced
changes in cTnC structure) was reduced at 2.0 compared
with 2.3 mm SL (Fig. 7). These results are discussed in the
context of the ability of strong-binding cross-bridges to
cooperatively activate cardiac thin filaments, thereby
contributing to length-dependent activation and the Frank-
Starling mechanism.
Cooperative thin-ﬁlament activation
by cross-bridges
In striated muscle, Ca2þ binding to the Ca2þ-binding subunit
of Tn (TnC) is the initial event that leads to movement of Tm
on the thin-filament surface, thereby allowing the transition
of cross-bridges from weak-binding to strong-binding,
force-producing states. Strong-binding cross-bridges further
displace Tm into the activating position, exposing additional
strong-binding sites on actin (1,4). Recent structural
evidence indicates that even in the absence of Ca2þ, thin fila-
ments exist in an equilibrium between Tm positions that
block or allow initial weak cross-bridge binding, and that
Ca2þ binding to Tn favors displacement of Tm partially
toward the activating position (23). Thus, biochemical and
structural studies substantiate the need for both Ca2þ binding
by Tn and subsequent strong cross-bridge/thin-filament
interaction to activate thin filaments in both skeletal and
cardiac muscle (1,4). We recently suggested that thin-fila-
ment activation is submaximal in cardiac muscle, even at
saturating [Ca2þ] (24). This idea is supported by structural
studies of isolated cTnC (25,26), isolated thin filaments
(27), and force measurements from single regulated thin fila-
ments that were reconstituted with cardiac Tn (28). The
implied lower capacity of Ca2þ binding to activate cardiac
thin filaments may make the level of thin-filament activation
particularly sensitive to modulation of the cross-bridge
component of activation by changes in SL and/or MFLS.
Furthermore, a unique feature of cardiac muscle is the ability
of strong-binding, force-generating cross-bridges to increase
Ca2þ binding to cTnC (Fig. 7) (5–8). This constitutes anBiophysical Journal 96(9) 3692–3702additional and potentially important feedback pathway for
thin-filament activation by cross-bridges in the presence of
Ca2þ. Thus, the steep SL dependence of force in cardiac
muscle could result from both the diminished capability of
Ca2þ to activate thin filaments and the ability of SL/MFLS
to modulate strong cross-bridge binding and the cooperative
contributionof strongcross-bridges to thin-filament activation.
Effects of SL and MFLS on thin-ﬁlament activation
by strong cross-bridges
If the central thesis is correct (i.e., that the SL dependence of
activation results from SL and MFLS modulation of strong
cross-bridge binding and allosteric activation of cardiac
thin filaments by cross-bridges), inhibition of strong cross-
bridge binding should mimic the decreased Ca2þ sensitivity
of force observed when SL is decreased or MFLS increased.
In support of this idea, we found that increasing [Vi] and
inhibition of strong cross-bridge/thin-filament interaction
(Fig. 5) decreased pCa50 (Figs. 2 and 3 B, Table 1). Further-
more, increasing [Vi] decreased the dependence of force-
[Ca2þ] relations on SL (Figs. 2–4) and MFLS (Fig. 6). The
latter seems at odds with other interventions, such as lower
pH and elevated phosphate (of which Vi is an analog), that
also inhibit cardiac force (29). Fukuda et al. (29) showed
that the SL dependence of pCa50 increased with lower pH
and elevated [Pi]. However, force inhibition by both Hþ
and elevated [Pi] likely differs from inhibition by Vi
because both Hþ and Pi may be in rapid equilibrium with
the entire cross-bridge population, particularly in the case
of Pi (30). This may contrast with Vi, where force generation
likely results from cross-bridges with no Vi-bound, whereas
the remainder are in a stable, weak-binding state (11). This
idea is supported by a comparison of chord stiffness
measurements that demonstrated a shift of the stiffness-
stretch rate relation toward higher stretch rates and implied
faster cross-bridge kinetics with elevated Pi, whereas Vi
increased stiffness only at low stretch rates (11). On the other
hand, our results are compatible those of Fukuda et al. (29)
when force enhancement by increasing SL over the entire
force-[Ca2þ] relation is considered. For example, at interme-
diate levels of force inhibition that compare with those at pH
6.2 and 20 mM Pi (29), the relative enhancement of force
with increasing SL at pCa> 5.6 was greater than in uninhib-
ited controls (Fig. 4 B; discussed below).
Increasing [Vi] not only decreased pCa50, it also altered
the SL dependence of Fmax (Fig. 3 A). When force was in-
hibited to ~66% (0.05 mM Vi) and ~40% (0.1 mM Vi)
Fmax at 2.3 mm SL, the ratio of maximal force at long versus
short SL (Fmax2.3/Fmax2.0) increased, reflecting relatively
greater inhibition at short SL at a given [Vi] (Fig. 1). Further
inhibition of Fmax to 20% reduced the effect of SL on Fmax.
Because [Ca2þ] was maximal, these results suggest that the
SL dependence of Fmax was not the result of altered myofil-
ament overlap alone. A possible explanation is that at
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population, the sensitivity of thin-filament activation to
SL- or MFLS-induced changes in cross-bridge binding was
enhanced. On the other hand, when the cross-bridge popula-
tion is reduced to ~20% at 0.30 mM Vi, cross-bridges may
not contribute significantly to thin-filament activation,
reducing any influence changes in SL or MFLS may have
on force at saturating [Ca2þ].
Several additional lines of evidence support the idea that
the dependence of thin-filament activation state on strong
cross-bridge binding likely underlies increased pCa50 and
Fmax when SL increases or MFLS decreases, as observed by
us (Figs. 2 and 3, Table 1) andmany others (1,2). For example,
the SL dependence of force-[Ca2þ] relations decreased
whether strong cross-bridge binding was enhanced by
lowering [ATP] (9) or increasing [ADP] (31). Addition of
strong, noncycling cross-bridges (exogenous NEM subfrag-
ment 1) likewise leads to elevated thin-filament activation
and reduced SL dependence of cardiac force (32). Similarly,
when skeletal muscle myofibrils are submaximally activated
by elevated [MgADP] without Ca2þ, increasing SL over a
range that decreased myofilament overlap, and decreased
MFLS both enhanced force (33). In contrast, at higher
[MgADP] and greater activation, increasing SL caused force
to decrease with decreasing myofilament overlap. The
enhancement of force by increasing SL (and decreasing
MFLS) at submaximal activation by MgADP-bound cross-
bridges, despite decreasing filament overlap, was attributed
to increased cross-bridge proximity and binding to thin fila-
ments, leading to greater activation (33). Thus, conditions
that increase cross-bridge binding to thin filaments tend to
reduce the effects of SL or MFLS on force in both skeletal
and cardiac muscle. Of interest, reduction in the SL depen-
dence of force is not restricted to conditions that increase
strong cross-bridge binding. Lowered ionic strength (34)
and temperature (35) both favor an increased population of
weak-binding cross-bridge states (10) and reduce the SL
dependence of force. This implies that when weak cross-
bridge binding is enhanced, changes in SL or MFLS induce
much smaller relative changes in initial weak binding.
Furthermore, we demonstrated that decreasing MFLS
enhanced ‘‘weak’’ cross-bridge/thin-filament interaction in
skinned cardiac trabeculae (10). These data led to the sugges-
tion that changes in SL or MFLS may modulate force in the
presence of Ca2þ by controlling the probability of the initial
weak-binding cross-bridge state (2). On the other hand, there
is some controversy regarding whether SL-dependent
changes in MFLS modulate force-[Ca2þ] relations in cardiac
muscle (36), although more recent evidence indicates that
MFLS may modulate the Ca2þ sensitivity of cardiac force
(37). This important issue was recently reviewed (2).
Although elevated populations of weak- or strong-binding
states reduce the length dependence of activation, we found
that reduction of the population of cycling cross-bridges by
more than ~60% of maximal also reduced the effects of SL(Fig. 2, 3 B, 4) and MFLS (Fig. 6) on cardiac force-[Ca2þ]
relations. This is consistent with the idea that when force
and cross-bridge binding are inhibited to this level, the
contribution of cycling, strongly bound cross-bridges to
cooperatively activate cardiac thin filaments is reduced to
the extent that changes in SL or MFLS will result in little
or no change in thin-filament activation. Although both
enhancement of strong cross-bridge/thin-filament interaction
and inhibition of cross-bridge binding by Vi decrease the SL
dependence of cardiac force-[Ca2þ] relations, there is an
important difference. Enhancement of strong cross-bridge/
thin-filament interaction by NEM-S1, elevated ADP, or
low ATP reduced SL effects on force-[Ca2þ] relations by
predominantly increasing pCa50 at short SL, with little effect
at longer SL. In contrast, the data in Fig. 3 B and Table 1
indicate that increasing [Vi] (0–0.30 mM) decreased pCa50
more at the longer SL (0.19 vs. 0.14 pCa units). Thus the
effect of Vi on pCa50 was greatest when the population of
cycling cross-bridges was largest and contributing signifi-
cantly to thin-filament activation. In contrast, at short SL
and with less strong cross-bridge binding, the smaller effect
of Vi on pCa50 could reflect a reduction of the cross-bridge
component of activation. Under these conditions, activation
could depend primarily on Ca2þ binding to cTnC, which has
been shown to be unaffected by SL or MFLS in cardiac
muscle when force is inhibited (5–7,22).
Evidence for cooperative thin-ﬁlament activation
by strong cross-bridges
The idea that the ability of strong cross-bridges to coopera-
tively activate cardiac thin filaments depends on the size of
the cycling cross-bridge population is supported by the fluo-
rescence data in Fig. 7. When relating the data in Fig. 7 to
reduced SL dependence of force at the highest [Vi] (Figs.
2 and 3), one should consider that peak myoplasmic
[Ca2þ] is submaximal in intact cardiac myocytes (18). The
proportional decrease in force and stiffness when [Ca2þ]
decreases in skinned trabeculae (Fig. 5) suggests that in my-
ocytes the population of cycling bridges is likewise reduced.
At this submaximal level of strong cross-bridge binding,
further reduction of the cross-bridge population from
decreasing SL (increasing MFLS) could reduce thin-filament
activation by cross-bridges, further contributing to a steep
decrease in activation and force. Inhibition of maximal force
with 1 mM Vi caused dichroism to decrease by ~14% of the
difference between relaxed (pCa 9.2) and maximal Ca2þ
activation (pCa 4.5) (Fig. 7 A). Although this difference
was small, the sensitivity of the 50IATR probe to structural
changes induced by Ca2þ binding to cTnC site II, or to those
induced by strong cross-bridge binding to thin filaments,
may not be the same. This makes it difficult to attribute the
change of dichroism with 1 mM Vi to a specific change in
the thin-filament activation state. However, at 2.3 mm SL,
inhibition of strong cross-bridge binding caused less changeBiophysical Journal 96(9) 3692–3702
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stiffness (Fig. 5), indicating that thin-filament activation by
cross-bridges was cooperative. If this were not the case,
and each strong cross-bridge made an equivalent contribu-
tion to thin-filament activation, the component of cTnC
structural change induced by strong cross-bridges should
have declined in direct proportion to reduced force and stiff-
ness with increasing [Vi]. Of interest, at short SL, dichroism
and force declined more proportionately with increasing
[Vi]. This is consistent with the idea that at short SL and
reduced force, the population of cycling cross-bridges at
a given [Vi] fell below the level needed to sustain coopera-
tive thin-filament activation, contributing to the steep decline
in force at the shorter SL.
The apparent effects of force inhibition on cTnC structure
are in stark contrast to skeletal fibers, where changes in SL or
inhibition of force do not alter the relationship between free
[Ca2þ] and either Ca2þ bound to thin filaments (6,38) or
Ca2þ-induced changes in TnC structure (7). This observation
does not indicate that skeletal thin-filament activation is
insensitive to strong cross-bridge binding, just that it is not
associated with increased Ca2þ binding to skeletal TnC.
Further, cardiac force-[Ca2þ] relations are more sensitive
to SL than skeletal fibers (39). We have proposed that the
ability of force-generating cross-bridges to enhance Ca2þ
binding to cTnC increases the sensitivity of cardiac thin-fila-
ment activation to SL- and/or MFLS-induced changes in
strong cross-bridge binding. One could speculate that the
molecular basis of this sensitivity resides in thin-filament
regulatory protein isoform differences between cardiac and
skeletal muscle. For example, the smaller ‘‘opening’’ of
the N-terminal domain of cTnC in response to Ca2þ binding
to the single Ca2þ regulatory site (25,40) compared with
a much larger response to Ca2þ binding to the two regulatory
sites on skeletal TnC (41) may contribute to the greater
apparent dependence of cardiac thin-filament activation on
cross-bridges. Additionally, important differences between
the skeletal and cardiac isoforms of TnI or TnT could deter-
mine the relative sensitivity of the interaction between TnC
and TnI to strong cross-bridge binding during Ca2þ activa-
tion. These ideas are speculative and require experimental
validation.
The fluorescent data in Fig. 7 and the slope (nH) of cardiac
force-[Ca2þ] relations suggest that the processes underlying
thin-filament activation and force generation are cooperative.
On the other hand, nH was not significantly altered by
changes in SL or force inhibition with Vi (Table 1). This
observation is consistent with other studies (9,42) and
suggests that the apparent cooperativity of cardiac force-
[Ca2þ] relations (nH) was not influenced by the size of the
strong cross-bridge population. This lack of sensitivity of
nH to changes in SL or altered cross-bridge binding is diffi-
cult to explain and beyond the scope of this study. However,
it is likely that multiple interactions determine nH in both
skeletal and cardiac muscle. These interactions could includeBiophysical Journal 96(9) 3692–3702strong cross-bridge enhancement of cTnC affinity for Ca2þ,
spread of activation between adjacent thin-filament regula-
tory units, Tm displacement, and spread of activation from
strong cross-bridges and potential cross-bridge/cross-bridge
interactions. Further, the properties of Tn subunits and/or
Tm may contribute to nH. Supporting this complexity are
observations that disruption of thin-filament regulatory unit
interaction decreased both pCa50 and nH in skeletal fibers
(43), whereas similar experiments with cardiac muscle did
not significantly alter the slope of force-[Ca2þ] relations
(44).
Taken together, the results indicate that when the cycling
population of cross-bridges is large enough to support coop-
erative activation of cardiac thin filaments (Fig. 7), changes
in cross-bridge binding from alteration of SL or MFLS have a
significant impact on the Ca2þ sensitivity (pCa50) of cardiac
force. Thus, a minimal cycling cross-bridge population may
be necessary during contraction to maintain the steep SL
dependence of force and the Frank-Starling mechanism in
cardiac muscle.
Effects of intermediate force inhibition
on SL-dependent activation
When the effects of SL on force are considered over the full
range of activating [Ca2þ], as illustrated in Fig. 4, the results
indicate that force inhibition reduces the absolute difference
in force at 2.0 and 2.3 mm SL, particularly at submaximal
[Ca2þ] (Fig. 4 A). However, when the data are normalized
to maximum force at long SL for each [Vi] (Fig. 4 B), force
inhibition to 60% and 40% of control reduced the effect of
increasing SL on force at lower [Ca2þ] (pCa > 5.6), but re-
sulted in greater force enhancement at higher [Ca2þ] than in
controls (Fig. 4 B). In contrast, when maximal force at long
SL was inhibited to ~20% of control, the influence of SL on
force at all activating [Ca2þ] was significantly reduced
(Fig. 4 B). A possible explanation for these results is that,
to maintain the SL or MFLS dependence of force, cardiac
thin filaments are ‘‘tuned’’ to require both Ca2þ binding to
cTnC and allosteric, cooperative activation by cross-bridges
to achieve a given level of activation, even at unphysiologi-
cal saturating [Ca2þ] (Fig. 3 A). Under these conditions,
SL- and MFLS-induced changes in the probability of cross-
bridge/thin-filament interaction would have a maximal
impact on thin-filament activation and force. This idea offers
a potential explanation for the enhanced effect of SL on force
at higher [Ca2þ] (pCa < 5.6) in skinned trabeculae when
Fmax is inhibited by 40% and 60%, as well as for the signif-
icant reduction in SL sensitivity that results when force is
further inhibited (Fig. 4 B). In the first case, thin-filament
response to Ca2þ and strong cross-bridge binding is tuned
such that an intermediate reduction of strong cross-bridge
binding, whether from reduced activating [Ca2þ] or a reduc-
tion in SL (increased MFLS), further sensitizes thin-filament
activation to changes in strong cross-bridge binding. This
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components are such that cardiac activation is maintained
within a range that is submaximal for force generation but
maximally sensitive tomodulation of the cross-bridge compo-
nent of activation by altered SLorMFLS.On the other hand, if
the population of cycling cross-bridges falls by more than
~60%, the cross-bridge component of activation is diminished
to the point that small changes in binding from altered SL or
MFLS will have little effect on activation, leading to a reduc-
tion or loss of the Frank-Starling mechanism.
These results emphasize the complex nature of thin-fila-
ment activation in cardiac muscle and support the idea that
length, via the accompanying changes in MFLS, modulates
force and the Ca2þ sensitivity of force by regulating the
probability of cooperative thin-filament activation by cross-
bridges. Furthermore, in cardiac muscle the level of thin-fila-
ment activation from Ca2þ binding to Tn and strong-binding
cross-bridges may be tuned to promote the steep SL depen-
dence of contractile force that allows the heart to function as
an adaptive pump that is responsive to changes in venous
return and metabolic demand.
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